楼主: urakee
1101 1

[学科前沿] 日本的专利系统与商业创新(共31页) [推广有奖]

  • 0关注
  • 4粉丝

副教授

6%

还不是VIP/贵宾

-

威望
0
论坛币
74028 个
通用积分
4.3288
学术水平
24 点
热心指数
41 点
信用等级
10 点
经验
25795 点
帖子
413
精华
0
在线时间
578 小时
注册时间
2007-11-6
最后登录
2023-6-25

相似文件 换一批

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
Japan's Patent System and Business Innovation: Reassessing Pro-patent Policies
by
Kazuyuki Motohashi
Institute of Innovation Research, Hitotsubashi University and RIETI
Abstract
Since current Japanese patent law was enacted in 1959, it has been revised several times,
mainly for the purpose of international harmonization. Recently the Japanese government
stresses the importance of pro-patent policies, i.e., strengthening intellectual property right in
order to stimulate business innovation and to regain international competitiveness. This paper
assesses the impact of series of revisions of Japanese patent system on firm’s innovation
activities, by using statistical data, firm level survey data and information from interviews for
IP managers in IT and pharmaceutical firms.
It is found that increases in patent application in the late 1990’s are attributed to a surge of IT
patents, as well as pharmaceutical ones. For IT and pharmaceuticals, technology fields covered
by patent protection have been gradually expanded, such as in areas of software and
biotechnology. This policy change may contribute to increase in patent application. However,
it is difficult to separate this system factor from other factors such as expansion of
technological opportunity.
Although the impact of recent pro-patent policies on firm’s innovation is not so clear, it is
clear that IP section inside firm becomes to play more active role in firm’s innovation strategy
formulation, particularly in pharmaceutical firms. Tremendous technology opportunities in IT
and biotech push a firm to rely on external knowledge pools by licensing activities, and it
becomes important to coordinate in-house R&D with licensing activities to tap on external
technology sources. In this context, IP section involves heavily in R&D and product
development process inside firm. In addition, it is found that large firms in IT and
pharmaceutical industry, focuses on US patent system, which moves relatively quickly for new
technology field patenting, and pay less attention to Japanese one.
Keywords: Pro-patent policies, innovation, biotechnology, information technology
二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

关键词:intellectual information Application Internation competitive University Recently property Business business

03e020.pdf

291.35 KB

需要: 300 个论坛币  [购买]

沙发
qinhan312 发表于 2014-3-16 15:34:33 |只看作者 |坛友微信交流群
一般一般

使用道具

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
加JingGuanBbs
拉您进交流群

京ICP备16021002-2号 京B2-20170662号 京公网安备 11010802022788号 论坛法律顾问:王进律师 知识产权保护声明   免责及隐私声明

GMT+8, 2024-5-17 13:51